Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Jørgensen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|October 28, 2021
[Lymphoid malignancy treatment]Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ugeskrift for Laeger|October 28, 2021
[Lymphoid malignancy diagnostics]Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ejhaem|September 2, 2022
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphomaHeli Vajavaara, Suvi-Katri Leivonen, Judit Jørgensen, et al.
Cancers|January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell LymphomaHeli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Leukemia|April 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomasMaare Arffman, Leo Meriranta, Judit Jørgensen, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group StudyJorne L Biccler, Sandra Eloranta, Peter de Nully Brown, et al.
Leukemia & Lymphoma|November 10, 2020
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohortCharlotte Madsen, Trine Lindhardt Plesner, Hans Herluf Bentzen, et al.
Clinical Epidemiology|November 9, 2016
Danish National Lymphoma RegistryBente Arboe, Pär Josefsson, Judit Jørgensen, et al.
British Journal of Haematology|November 9, 2018
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclinesJoachim Baech, Steen M Hansen, Peter E Lund, et al.
Med (New York, N.Y.)|April 5, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomasMaare Arffman, Leo Meriranta, Matias Autio, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|October 28, 2021
[Lymphoid malignancy treatment]Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ugeskrift for Laeger|October 28, 2021
[Lymphoid malignancy diagnostics]Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ejhaem|September 2, 2022
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphomaHeli Vajavaara, Suvi-Katri Leivonen, Judit Jørgensen, et al.
Cancers|January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell LymphomaHeli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Leukemia|April 22, 2026
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomasMaare Arffman, Leo Meriranta, Judit Jørgensen, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group StudyJorne L Biccler, Sandra Eloranta, Peter de Nully Brown, et al.
Leukemia & Lymphoma|November 10, 2020
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohortCharlotte Madsen, Trine Lindhardt Plesner, Hans Herluf Bentzen, et al.
Clinical Epidemiology|November 9, 2016
Danish National Lymphoma RegistryBente Arboe, Pär Josefsson, Judit Jørgensen, et al.
British Journal of Haematology|November 9, 2018
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclinesJoachim Baech, Steen M Hansen, Peter E Lund, et al.
Med (New York, N.Y.)|April 5, 2024
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomasMaare Arffman, Leo Meriranta, Matias Autio, et al.
Pageof 3